Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 22

Trial Status

Completed1
Other1

Role Distribution

Other Roles2

Activity Timeline

Clinical Trials (2)

NCT06116890Phase 2Completed
Study to Assess the Efficacy & Safety of KHK4951 in Patients With Neovascular Age-Related Macular Degeneration
Neovascular Age-Related Macular Degeneration (nAMD)
StudydirectorStart date: 2024-01-31
NCT06116916Phase 2Active Not Recruiting
Study to Assess the Efficacy & Safety of KHK4951 in Patients With Diabetic Macular Edema
Diabetic Macular Edema (DME)
StudydirectorStart date: 2024-01-09

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Amir Shojaei, PhD

Asclepix Therapeutics

Moderately Similar
2 trials

Shared therapeutic areas:

Diabetic Macular Edema (DME)Neovascular Age-related Macular Degeneration (nAMD)
Similarity Score30%

Dong Geun Kim

Inje University

Related
1 trials

Shared therapeutic areas:

Neovascular Age-related Macular Degeneration (nAMD)
Similarity Score15%

Sean Adrean, M.D.

Retina Consultants of Orange County

Related
1 trials

Shared therapeutic areas:

Diabetic Macular Edema (DME)
Similarity Score15%

J. Pablo Velazquez-Martin, MD

Kodiak Sciences Inc

Related
1 trials

Shared therapeutic areas:

Diabetic Macular Edema (DME)
Similarity Score15%

Iksoo Byon

Pusan National University Hospital

Related
1 trials

Shared therapeutic areas:

Neovascular Age-related Macular Degeneration (nAMD)
Similarity Score15%

Diana V Do, MD

Johns Hopkins University

Related
2 trials

Shared therapeutic areas:

Diabetic Macular Edema (DME)
Similarity Score15%

Sharon Klier, MD, MPH

Unity Biotechnology, Inc.

Related
2 trials

Shared therapeutic areas:

Diabetic Macular Edema (DME)
Similarity Score15%

Kyu Hyeong Park

Seoul National University HospitalSeoul National University Hospital

Related
1 trials

Shared therapeutic areas:

Neovascular Age-related Macular Degeneration (nAMD)
Similarity Score15%

Zhiqing Chen, M.D.

Eye Center, The Second Affiliated Hospital, School of Medicine, Zhejiang University

Related
1 trials

Shared therapeutic areas:

Diabetic Macular Edema (DME)
Similarity Score15%

Charles Miller, MD PhD

EyeBiotech Ltd.

Related
3 trials

Shared therapeutic areas:

Diabetic Macular Edema (DME)
Similarity Score15%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT06116890Phase 2StudyDirector

Study to Assess the Efficacy & Safety of KHK4951 in Patients With Neovascular Age-Related Macular Degeneration

Neovascular Age-Related Macular Degeneration (nAMD)
Completed
NCT06116916Phase 2StudyDirector

Study to Assess the Efficacy & Safety of KHK4951 in Patients With Diabetic Macular Edema

Diabetic Macular Edema (DME)
Active Not Recruiting

All 2 trials loaded